Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 142

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 4A
Chunk 142
---
 in general, approval by a majority of our shareholders present and voting (in person
or by proxy) at a meeting of shareholders, subject to fulfillment of one of the two additional conditions described in “ Item 6.
Directors, Senior Management and Employees - C. Board Practices - Approval of Related Party Transactions under Israeli Law - Disclosure
of Personal Interests of an Office Holder and Approval of Certain Transactions.” As approved by our annual general meeting of shareholders
on August 10, 2021, the annual cash bonus measurable performance objectives of our CEO, Mr. Ofer Haviv may be determined annually by the
Compensation Committee and the Board.

Each of the employment agreements with our executive officers contains
provisions regarding non-competition, confidentiality of information and assignment of inventions. The non-competition provision applies
for a period that is generally 12 months following termination of employment. The enforceability of covenants not to compete in Israel
and in the United States is subject to limitations. The employment agreement of each executive officer is terminable upon between 30 to
90 days’ written notice by either party to the agreement.

83

Director Compensation

Our directors are entitled to cash compensation and equity compensation
as follows:

Cash Compensation of
Directors

All of our directors receive annual fees and per-meeting fees
for their service on our board and its committees, in the following amounts:

  Annual fees in an amount of approximately $24,000 for directors classified as experts; and  

  Per-meeting fees in an amount of approximately $1,300 for directors classified as experts; 60% of such amounts for participation  

Such amounts are within the range for cash compensation for
external and unaffiliated directors of a company of our size (based on level of shareholders’ equity) under the Companies Law.

Cash Compensation of
Chairperson of the Board

In accordance with shareholders’ approval from August
2021, a chairperson of the board who is determined by the Board to be an “active chairperson” in light of increased involvement
in our activities and increased time investment in the performance of the duties accompanying the chairperson’s position compared
to the other directors, shall be entitled to increased compensation relative to our other directors of approximately $6,600 per month.
Our Board has determined that Mr. Nir Nimrodi, our chairperson of the board, is an active chairperson, and accordingly his fees as active
chairperson is as aforesaid.

Equity Compensation of
Directors